Recent News

• 06.11.2025 - Adial Pharmaceuticals Advances Toward Phase 3 Development for AD04
• 05.15.2025 - Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
• 05.15.2025 - Adial Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update

Recent Filings

• 06.10.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 06.10.2025 - ARS Annual Report to Security Holders
• 06.10.2025 - DEF 14A Other definitive proxy statements
• 06.09.2025 - EFFECT Notice of Effectiveness
• 06.06.2025 - S-1 General form for registration of securities under the Securities Act of 1933
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities
• 06.02.2025 - 4 Statement of changes in beneficial ownership of securities